These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33541830)

  • 1. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts.
    Heidarian A; Das KK; Mino-Kenudson M; Fernandez-Del Castillo C; Pitman MB
    J Am Soc Cytopathol; 2021; 10(3):249-254. PubMed ID: 33541830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
    Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
    Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
    Das KK; Xiao H; Geng X; Fernandez-Del-Castillo C; Morales-Oyarvide V; Daglilar E; Forcione DG; Bounds BC; Brugge WR; Pitman MB; Mino-Kenudson M; Das KM
    Gut; 2014 Oct; 63(10):1626-34. PubMed ID: 24277729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent Accuracy of Glucose Level in Cystic Fluid for Diagnosis of Pancreatic Mucinous Cysts.
    Faias S; Pereira L; Roque R; Chaves P; Torres J; Cravo M; Pereira AD
    Dig Dis Sci; 2020 Jul; 65(7):2071-2078. PubMed ID: 31705344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts.
    Basar O; Yuksel O; Yang DJ; Samarasena J; Forcione D; DiMaio CJ; Wagh MS; Chang K; Casey B; Fernandez-Del Castillo C; Pitman MB; Brugge WR
    Gastrointest Endosc; 2018 Jul; 88(1):79-86. PubMed ID: 29510146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy in pancreatic cysts with cytology of high-grade epithelial atypia.
    Hoda RS; Lu R; Arpin RN; Rosenbaum MW; Pitman MB
    Cancer Cytopathol; 2018 Sep; 126(9):773-781. PubMed ID: 30257067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
    Smith AL; Abdul-Karim FW; Goyal A
    Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.
    Matthaei H; Wylie D; Lloyd MB; Dal Molin M; Kemppainen J; Mayo SC; Wolfgang CL; Schulick RD; Langfield L; Andruss BF; Adai AT; Hruban RH; Szafranska-Schwarzbach AE; Maitra A
    Clin Cancer Res; 2012 Sep; 18(17):4713-24. PubMed ID: 22723372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts.
    Rosenbaum MW; Jones M; Dudley JC; Le LP; Iafrate AJ; Pitman MB
    Cancer Cytopathol; 2017 Jan; 125(1):41-47. PubMed ID: 27647802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
    Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
    Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts.
    Al-Haddad M; DeWitt J; Sherman S; Schmidt CM; LeBlanc JK; McHenry L; Coté G; El Chafic AH; Luz L; Stuart JS; Johnson CS; Klochan C; Imperiale TF
    Gastrointest Endosc; 2014 Jan; 79(1):79-87. PubMed ID: 23845445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
    Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
    Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm.
    Allen PJ; Qin LX; Tang L; Klimstra D; Brennan MF; Lokshin A
    Ann Surg; 2009 Nov; 250(5):754-60. PubMed ID: 19806054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology from pancreatic cysts has marginal utility in surgical decision-making.
    Maker AV; Lee LS; Raut CP; Clancy TE; Swanson RS
    Ann Surg Oncol; 2008 Nov; 15(11):3187-92. PubMed ID: 18766406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Molecular Analysis into the Pathologic Evaluation of Pancreatic Cysts.
    Bell PD; Singhi AD
    Surg Pathol Clin; 2022 Sep; 15(3):455-468. PubMed ID: 36049828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
    Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
    Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.